Lessons from Hepatitis C Treatment During the COVID-19 Pandemic: Decreased Resource Utilization Leads to Similar Efficacy in British Columbia, Canada
May 2022
in “
Gastroenterology
”
Studysummary This study suggests that supplemental testosterone therapy in men with hepatitis C virus may be associated with a modest reduction in hepatocellular carcinoma risk, challenging concerns about its potential to increase cancer risk.
Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
Read the full study on gastrojournal.org →